Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexios Tzivanakis

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 16, 2022
Early postoperative intraperitoneal chemotherapy (EPIC) following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in 632 patients with pseudomyxoma peritonei of appendiceal origin: A single institution experienceXavier Fung, I Chuan Li, Kandiah Chandrakumaran, et al.
European Journal of Clinical Nutrition|November 22, 2020
Outcomes of home parenteral nutrition in 34 patients with intestinal failure from recurrent or progressive peritoneal malignancy of gastro-intestinal tract originDavid Swain, Gemma Mason, Allison Yates, et al.
Pleura and Peritoneum|March 27, 2019
Do patients undergoing cytoreductive surgery and HIPEC for peritoneal malignancy need parenteral nutrition?David R Swain, Allison L Yates, Faheez Mohamed, et al.
Annals of Surgical Oncology|November 3, 2021
Overall Survival is More Closely Associated with Peritoneal than Primary Appendiceal Pathological Grade in Pseudomyxoma Peritonei with Discordant PathologyAyaz Ahmed Memon, Chintamani Godbole, Tom Cecil, et al.
Journal of Surgical Case Reports|May 18, 2026
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy can be safely combined with nephrectomy in patients with appendiceal malignancy and synchronous renal cell carcinomaSiu Y Kok, Faheez Mohamed, Brendan J Moran, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|June 6, 2021
Indications and long-term outcomes of preoperative inferior vena caval filters in 111 patients at high risk of pulmonary embolism undergoing major abdominal surgeryDanko Kostadinov, Alexios Tzivanakis, Gaurang Ubhayakar, et al.
Indian Journal of Surgical Oncology|June 26, 2023
Pseudomyxoma Peritonei Arising from Urachal Mucinous Neoplasms: a Case Series and Updated Literature ReviewNiccolo Allievi, Vasanth Mark Samuel, Norman Carr, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|February 5, 2021
Patients undergoing cytoreductive surgery for peritoneal malignancy of appendiceal origin should be consented for umbilical excision as 30% have umbilical infiltrationShinichiro Sakata, Tun G Tan, Danko Kostadinov, et al.
ANZ Journal of Surgery|March 19, 2021
Complete pathological response after ceritinib for anaplastic lymphoma kinase-rearranged epithelioid peritoneal mesotheliomaShinichiro Sakata, Helen Rees, Simon Parke, et al.
Annals of Surgical Oncology|May 27, 2021
Managing Recurrent Pseudomyxoma Peritonei in 430 Patients After Complete Cytoreduction and HIPEC: A Dilemma for Patients and SurgeonsNima Ahmadi, Danko Kostadinov, Shinichiro Sakata, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 16, 2022
Early postoperative intraperitoneal chemotherapy (EPIC) following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in 632 patients with pseudomyxoma peritonei of appendiceal origin: A single institution experienceXavier Fung, I Chuan Li, Kandiah Chandrakumaran, et al.
European Journal of Clinical Nutrition|November 22, 2020
Outcomes of home parenteral nutrition in 34 patients with intestinal failure from recurrent or progressive peritoneal malignancy of gastro-intestinal tract originDavid Swain, Gemma Mason, Allison Yates, et al.
Pleura and Peritoneum|March 27, 2019
Do patients undergoing cytoreductive surgery and HIPEC for peritoneal malignancy need parenteral nutrition?David R Swain, Allison L Yates, Faheez Mohamed, et al.
Annals of Surgical Oncology|November 3, 2021
Overall Survival is More Closely Associated with Peritoneal than Primary Appendiceal Pathological Grade in Pseudomyxoma Peritonei with Discordant PathologyAyaz Ahmed Memon, Chintamani Godbole, Tom Cecil, et al.
Journal of Surgical Case Reports|May 18, 2026
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy can be safely combined with nephrectomy in patients with appendiceal malignancy and synchronous renal cell carcinomaSiu Y Kok, Faheez Mohamed, Brendan J Moran, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|June 6, 2021
Indications and long-term outcomes of preoperative inferior vena caval filters in 111 patients at high risk of pulmonary embolism undergoing major abdominal surgeryDanko Kostadinov, Alexios Tzivanakis, Gaurang Ubhayakar, et al.
Indian Journal of Surgical Oncology|June 26, 2023
Pseudomyxoma Peritonei Arising from Urachal Mucinous Neoplasms: a Case Series and Updated Literature ReviewNiccolo Allievi, Vasanth Mark Samuel, Norman Carr, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|February 5, 2021
Patients undergoing cytoreductive surgery for peritoneal malignancy of appendiceal origin should be consented for umbilical excision as 30% have umbilical infiltrationShinichiro Sakata, Tun G Tan, Danko Kostadinov, et al.
ANZ Journal of Surgery|March 19, 2021
Complete pathological response after ceritinib for anaplastic lymphoma kinase-rearranged epithelioid peritoneal mesotheliomaShinichiro Sakata, Helen Rees, Simon Parke, et al.
Annals of Surgical Oncology|May 27, 2021
Managing Recurrent Pseudomyxoma Peritonei in 430 Patients After Complete Cytoreduction and HIPEC: A Dilemma for Patients and SurgeonsNima Ahmadi, Danko Kostadinov, Shinichiro Sakata, et al.
Pageof 3